ARCHIVES

Bill Reintroduced to Weaken U.S. Preventive Services Task Force

This article is from The Cancer Letter archive.

Vol. 39 No. 27 | July 3, 2013

Download PDF Visit The Full Archive

Related Articles

Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting

June 25, 2010

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

NCCS Networker Volume 4 Issue 4, Fall 1990

September 13, 1990

Breast Cancer Awareness High, Knowledge Of Facts Low,

October 5, 2007

NCI Advisors Approve Plan For Repository For Prostate Cancer Issue Specimens

March 19, 1999